Aleteia logoAleteia logo
Aleteia
Tuesday 13 April |
Saint of the Day: Pope St. Martin I
home iconLifestyle
line break icon

Morning-After Pill to Be Available Over-the-Counter to 15-Years-Olds

DR

Aleteia - published on 05/01/13

The New York Catholic Conference called the ruling a “recipe for disaster”

Washington D.C. – On April 30, the Food and Drug Administration approved over the counter sale of the morning-after pill Plan B One-Step to all women aged 15 and older.
Plan B One-Step is the name of the drug, made exclusively by Teva Women's Health, Inc., which acts as an emergency contraceptive which reduces the possibility of pregnancy when taken up to three days after sexual intercourse. It is taken as a single-dose 1.5 mg tablet of levonorgestrel.
Pharmacies and retailers with on-site pharmacies will have the drug on shelves, and those wishing to purchase it will have to provide proof of age. Teva has agreed to have a security tag placed on all Plan B One-Step cartons to prevent theft, according to the FDA.
Plan B is the same drug – levonorgestrel – as Plan B One-Step, but is taken in two doses of 0.75 mg per tablet. Plan B, which is available from generic manufacturers, requires a prescription for women under the age of 17.
Ella, another emergency contraceptive, is prescription-only.
In Dec. 2011, Health and Human Services secretary Kathleen Sebelius overruled the FDA’s plan to make the morning-after pill available over the counter and with no age limits citing “significant cognitive and behavioral differences” between older adolescent girls and the youngest girls of reproductive age.
Today's release claimed that a study submitted by Teva showed that women 15 years and older are able to understand the drug is not for routine use and does not protect against sexually transmitted diseases.
On April 5, a federal judge in Brooklyn, Edward Korman, had ordered the FDA to allow over the counter sale of Plan B to women of all ages, and/or make Plan B One-Step available without age restrictions.
The FDA said that today's approval of Plan B One-Step is independent of Korman's ruling, which caused outcry last month from pro-life and Catholic groups nationwide over perceived health risks to young women.
Dr. Charmaine Yoest of Americans United for Life called Korman's decision an opportunity for “big abortion industry to gamble with young girls’ health,” and the New York Catholic Conference called the ruling a “recipe for disaster.”

Originally published by the Catholic News Agency on April 30th, 2013.

Tags:
ContraceptionPro-life
Support Aleteia!

If you’re reading this article, it’s thanks to the generosity of people like you, who have made Aleteia possible.

Here are some numbers:

  • 20 million users around the world read Aleteia.org every month
  • Aleteia is published every day in seven languages: English, French, Italian, Spanish, Portuguese, Polish, and Slovenian
  • Each month, readers view more than 50 million pages
  • Nearly 4 million people follow Aleteia on social media
  • Each month, we publish 2,450 articles and around 40 videos
  • We have 60 full time staff and approximately 400 collaborators (writers, translators, photographers, etc.)

As you can imagine, these numbers represent a lot of work. We need you.

Support Aleteia with as little as $1. It only takes a minute. Thank you!

Daily prayer
And today we celebrate...




Top 10
1
JESUS
Fr Robert McTeigue, SJ
A simple test to see if you really believe Christ is risen
2
PRINCE PHILIP
Cerith Gardiner
11 Interesting facts about the late Prince Philip
3
SAINT FAUSTINA,CELL
Fr. Patrick Briscoe, OP
St. Faustina’s coffee cup and lessons for Divine Mercy Sund...
4
LOREN SCHAUERS
Annalisa Teggi
Amputee from the waist down is thankful every day to be alive
5
DIVINE MERCY
Aleteia
Here’s how to celebrate Divine Mercy Sunday at home
6
PADRE PIO
Philip Kosloski
St. Padre Pio: His life, his miracles and his legacy
7
HOLY SEPULCHRE CROSSES
Zelda Caldwell
Mystery of crosses on walls of Church of the Holy Sepulchre may h...
See More
Newsletter
Get Aleteia delivered to your inbox. Subscribe here.